4/22/19 – ArmaVir Invests in PAX Labs, Inc. as Part of its $420 Million Funding Round

ArmaVir Partners is pleased to announce its investment into PAX Labs, Inc., as part of its $420 million funding round. PAX Labs, a leading consumer technology brand, has secured $420 million in equity financing from global institutional investors representing technology, healthcare, consumer products and diversified public equities. The financing also received support from existing investors, including Tiger Global Management and Tao Capital Partners.

PAX is a leader in the design and development of premium app-controlled vaporization technologies and devices. Headquartered in San Francisco, PAX has revolutionized the consumer experience through innovation and product design, and is committed to taking the guesswork out of cannabis with products that offer quality, transparency and predictability. PAX has sold more than 500,000 Era devices for oil concentrates and over one million devices in the flower vaporizer category. PAX is committed to its mission: establishing cannabis as a force for good. For more information, please visit pax.com.